Sponsor pipeline

Can-Fite BioPharma clinical trial pipeline

Get alerts when Can-Fite BioPharma's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 2
2
Phase 3
2

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT05201404 Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With… Hepatocellular Carcinoma Recruiting 2025-04-29
NCT06643260 A Phase 3 Study in Moderate-to-Severe Plaque Psoriasis With Piclidenoson to Study Safety… Plaque Psoriasis Not Yet Recruiting 2025-04-29
Phase 2
NCT06387342 Namodenoson Treatment of Advanced Pancreatic Cancer Pancreatic Adenocarcinoma Recruiting 2025-01-31
NCT07410455 An Open-label, Phase 2 Pilot Study on the Efficacy and Safety of Piclidenoson in Patients… Lowe Syndrome Not Yet Recruiting 2026-02-18

Disease areas by active trials

Get alerts when Can-Fite BioPharma's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free